Decreased vagal tone and changes in sympathetic activity may precede the development of cardiometabolic disease or diabetes.
Read More »Jardiance Meets EMPEROR-Reduced Primary Endpoint
Diabetes drug shows benefit for heart failure patients with reduced ejection fraction.
Read More »Higher Intake of Protein Connected to Lower Mortality
Could a primarily plant-based high protein diet be the secret to longevity?
Read More »Reducing Cardiovascular Events and Mortality with Monthly Lifestyle Modification Counseling
Lifestyle modifications can impact cardiovascular outcomes including myocardial infarction, strokes, and death.
Read More »Long-Awaited Cardiovascular Efficacy and Safety Results From VERTIS-CV
Results from the VERTIS-CV trial suggest that ertugliflozin is not superior to placebo in reducing MACE but may reduce the rate of hospitalization for heart failure.
Read More »Sugar Intake Linked to Fat Deposits Around the Heart
Increased pericardial adipose tissue volume leads to coronary heart disease, coronary artery calcification, atrial fibrillation, and reduced left ventricular function.
Read More »Flu Vaccination for Better Diabetes Outcomes
Getting an annual flu vaccine could help lower complications associated with diabetes.
Read More »New Approval for Dapagliflozin to Treat Patients with Heart Failure
Beneficial cardiovascular results were consistent across subgroups regardless of diabetes status or medication combinations.
Read More »Pre-Diabetes Increases Risk of CVD and All-Cause Mortality
Numerous complications associated with diabetes, including the risk of death, begin at the pre-diabetic stage.
Read More »Do Pre-Diabetes Patients Fall into a Gray Zone?
Findings from a recently published meta-analysis of patients with pre-diabetes, with and without ASCVD, suggest an increased risk for premature death and cardiovascular events.
Read More »